Clinical Trials on SARS-CoV2 in Austria
Total 81 results
-
Medical University InnsbruckMedical University of Graz; Medical University of ViennaRecruiting
-
Medical University of GrazCompletedSymptoms Recoding SARS-CoV-2 After VaccinationAustria
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
Medical University of GrazTerminatedAnti-SARS-CoV-2 Antibody ResponseAustria
-
Medical University of ViennaUnknown
-
Glycovax Pharma Inc.Government of Canada; JSS Medical Research Inc.; Seppic; Avance Clinical Pty Ltd.Active, not recruiting
-
Medical University InnsbruckRecruitingSARS-CoV-2 | Post-acute COVID-19 SyndromeAustria
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
Murdoch Childrens Research InstituteRhinomed Pty LtdCompletedCOVID-19 | SARS CoV 2 InfectionAustralia
-
ModernaTX, Inc.Completed
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
ModernaTX, Inc.Biomedical Advanced Research and Development AuthorityCompleted
-
University of SydneyTelethon Kids Institute; Bionet Co., Ltd; Technovalia; Institute for Clinical Pathology...CompletedSARS-CoV2 COVID-19Australia
-
Medical University of ViennaMedical Scientific Fund of the Mayor of ViennaCompletedCritical Illness | Covid19 | Sars-CoV2 | Viral Infection | Disseminated Intravascular Coagulation | Coagulation Disorder, BloodAustria
-
ModernaTX, Inc.Completed
-
Medical University of ViennaUnknown
-
The University of QueenslandSyneos Health; Coalition for Epidemic Preparedness InnovationsCompletedCovid19 | SARS-CoV2Australia
-
Everly HealthCompletedSARS-CoV-2 Acute Respiratory DiseaseUnited States
-
University of MelbourneAustralian and New Zealand Intensive Care Research Centre; The Peter Doherty... and other collaboratorsActive, not recruitingSARS-CoV-2 Infection (COVID-19)Australia
-
Everly HealthCompletedSARS-CoV-2 Acute Respiratory DiseaseUnited States
-
Medical University InnsbruckUnknown
-
ModernaTX, Inc.Biomedical Advanced Research and Development AuthorityActive, not recruitingSARS-CoV-2United States, Dominican Republic
-
ModernaTX, Inc.National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...Completed
-
St. Anna KinderkrebsforschungCompletedCovid19 | SARS-CoV-2 Infection | Intestinal InfectionAustria
-
ModernaTX, Inc.Completed
-
Kepler University HospitalCompletedARDS Due to Disease Caused by SARS Co-V-2Austria
-
Memo Therapeutics AGCompletedSARS-CoV-2 InfectionAustralia
-
AUVAParacelsus Medical UniversityCompletedCoronavirus Infection | SARS-CoV 2 | Covid19 | Severe Acute Respiratory Syndrome Coronavirus 2Austria
-
University of MelbourneSouthern Star Research Pty Ltd.Completed
-
NGM Biopharmaceuticals, IncTerminated
-
Tonix Pharmaceuticals, Inc.CompletedCOVID-19 | Long COVID | Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection | Long Haul COVIDUnited States
-
University of MelbourneLondon School of Hygiene and Tropical Medicine; The Alfred; University of Adelaide and other collaboratorsRecruitingInfluenza, Human | SARS-CoV-2 InfectionAustralia
-
ACM BiolabsCompletedSARS-CoV-2 InfectionAustralia
-
St John of God Hospital, ViennaWithdrawn
-
ModernaTX, Inc.CompletedInfluenza | SARS-CoV-2United States
-
NovavaxCompletedCOVID-19 | SARS CoV 2 InfectionAustralia
-
Technovalia, Pty LtdChulalongkorn University; Southern Star Research Pty Ltd.; BioNet-AsiaActive, not recruitingCOVID-19, SARS CoV 2 InfectionAustralia
-
GlaxoSmithKlineCureVacActive, not recruitingSARS-CoV-2Australia, United States
-
Medical University InnsbruckLudwig-Maximilians - University of Munich; Deutsches Zentrum für Herz-Kreislauf-Forschung...Completed
-
ModernaTX, Inc.Active, not recruitingCytomegalovirus | SARS-CoV-2 | Seasonal Influenza | Respiratory Syncytial VirusUnited States
-
ModernaTX, Inc.Recruiting
-
Medical University of ViennaCompletedCritical Illness | Septic Shock | SIRSAustria
-
ModernaTX, Inc.Active, not recruitingA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsInfluenza | SARS-CoV-2United States
-
ModernaTX, Inc.CompletedInfluenza | SARS-CoV-2 | RSVUnited Kingdom, Australia, United States
-
NovavaxCompletedCovid19 | SARS-CoV InfectionAustralia
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
ModernaTX, Inc.Active, not recruitingInfluenza | SARS-CoV-2United States
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States
-
GlaxoSmithKlineCompletedCOVID-19 | SARS-CoV-2Australia, United States, Philippines
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand